Technology
Health
Biotechnology
InflaRx
$39.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$39.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.81 (-4.34%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
About
InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its products includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Employees
38,000
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
1.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
87.15K
High Today
$42.12
Low Today
$39.71
Open Price
$41.61
Volume
58.93K
52 Week High
$53.10
52 Week Low
$20.31
Collections
Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2017 IPO
Europe (Non-UK)
Price Paid on Robinhood
0% Higher
Right Now
52 Week Low
$20.31
Average Price Paid
$39.74
52 Week High
$53.10
Earnings
-$0.47
-$0.35
-$0.24
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 28, Pre-Market